Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-09-02-Speech-2-205"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20030902.9.2-205"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"Mr President, I have two practical questions: last Saturday's breakthrough in the field of medicines does mean that many are apprehensive about whether or not this will work in practice. One of the things we could probably do now in the European Union, which possesses the capacity to produce its own generic medicines, is to declare that we are prepared to issue such a declaration of compulsory licensing
in cases where developing countries ask for those medicines. This would, as it were, be a gesture on our part which demonstrates that those medicines will actually be supplied in practice.
The other practical question concerns the blue box
Many fear that in agriculture, we will be using this blue box in order to again indirectly subsidise exports on a massive scale. Brazil has asked whether we are able to promise at this stage that we will be supporting this blue box – in other words the switch from product subsidy to blue-box subsidy – but that we will not be making improper use of it for the purpose of export subsidies. With this, we would really contribute to abolishing this export subsidy. I am interested to know whether this line of thinking is currently on the agenda or plays a part in our negotiators’ thinking."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples